Comparison between Vaidya Sane Ayurved Laboratories IPO and Shigan Quantum Technologies IPO.
Vaidya Sane Ayurved Laboratories IPO is a SME Fixed Price IPO proposed to list at NSE SME while Shigan Quantum Technologies IPO is a SME Fixed Price proposed to list at NSE SME.
| Vaidya Sane Ayurved Laboratories IPO | Shigan Quantum Technologies IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price | Fixed Price |
| Listing At | NSE SME | NSE SME |
| Lead Managers | First Overseas Capital Ltd. | Finshore Management Services Ltd. |
| Registrar | Bigshare Services Pvt.Ltd. | Kfin Technologies Ltd. |
| Market Maker | Bhh Securities Pvt.Ltd. | Nikunj Stock Brokers Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Vaidya Sane Ayurved Laboratories IPO is up to ₹19.20 Cr whereas the issue size of the Shigan Quantum Technologies IPO is up to ₹21.56 Cr. The final issue price of Vaidya Sane Ayurved Laboratories IPO is ₹73.00 per share and of Shigan Quantum Technologies IPO is ₹50.00 per share.
| Vaidya Sane Ayurved Laboratories IPO | Shigan Quantum Technologies IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Final) | ₹73.00 per share | ₹50.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Market Lot Size | 1600 shares | 3000 shares |
| Fresh Issue Size | 26,30,400 shares | 43,11,000 shares |
| Fresh Issue Size (Amount) | up to ₹19.20 Cr | up to ₹21.56 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 26,30,400 shares | 43,11,000 shares |
| Issue Size Total (Amount) | up to ₹19.20 Cr | up to ₹21.56 Cr |
Vaidya Sane Ayurved Laboratories IPO opens on Feb 10, 2022, while Shigan Quantum Technologies IPO opens on Feb 28, 2022. The closing date of Vaidya Sane Ayurved Laboratories IPO and Shigan Quantum Technologies IPO is Feb 15, 2022, and Mar 03, 2022, respectively.
| Vaidya Sane Ayurved Laboratories IPO | Shigan Quantum Technologies IPO | |
|---|---|---|
| Issue Open | Feb 10, 2022 | Feb 28, 2022 |
| Issue Close | Feb 15, 2022 | Mar 03, 2022 |
| Basis Of Allotment (Tentative) | Feb 18, 2022 | Mar 08, 2022 |
| Initiation of Refunds (Tentative) | Feb 21, 2022 | Mar 09, 2022 |
| Credit of Share (Tentative) | Feb 22, 2022 | Mar 10, 2022 |
| Listing date (Tentative) | Feb 23, 2022 | Mar 11, 2022 |
Vaidya Sane Ayurved Laboratories IPO P/E ratio is 28.29, as compared to Shigan Quantum Technologies IPO P/E ratio of 12.41.
| Vaidya Sane Ayurved Laboratories IPO | Shigan Quantum Technologies IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated)
| Company Financials (Restated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 90.08% | 100% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 66.34% | 73.63% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 28.29 | 12.41 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹76.75 Cr. | ₹86.08 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.09 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹2.22 | ₹2.77 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 15.84 | 20.84 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Vaidya Sane Ayurved Laboratories IPO Retail Individual Investors (RII) are offered 13,15,200 shares while in Shigan Quantum Technologies IPO retail investors are offered 13,15,200 shares. Qualified Institutional Buyers (QIB) are offered in Vaidya Sane Ayurved Laboratories IPO and in Shigan Quantum Technologies IPO.
| Vaidya Sane Ayurved Laboratories IPO | Shigan Quantum Technologies IPO | |
|---|---|---|
| Market Maker Reservation | 1,40,800 shares | 2,28,000 shares |
| NII | 13,15,200 shares | 21,54,000 shares |
| RII | 13,15,200 shares | 21,57,000 shares |
| Total | 26,30,400 shares | 43,11,000 shares |
Vaidya Sane Ayurved Laboratories IPO subscribed 2.82x in total, whereas Shigan Quantum Technologies IPO subscribed 17.95x.
| Vaidya Sane Ayurved Laboratories IPO | Shigan Quantum Technologies IPO | |
|---|---|---|
| NII (times) | 2.66x | 27.70x |
| RII (times) | 2.98x | 8.21x |
| Total (times) | 2.82x | 17.95x |
